Skip to content

Perception Prognosis, Goals of Treatment, and Communication

Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01401894
Enrollment
50
Registered
2011-07-25
Start date
2010-10-31
Completion date
2014-06-30
Last updated
2017-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Cancer, Esophageal Cancer, Gastric Cancer, Liver Cancer, Pancreatic Cancer

Keywords

advanced cancer

Brief summary

The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.

Detailed description

* Participants will be asked to answer a few basic questions regarding race, ethnicity, religion, relationship status, education, income, and living situation. * They will then be asked to complete a questionnaire which contains questions about their mood, spirituality, quality of life and their understanding of their treatment and prognosis and their communication with their oncologist. They will complete these questionnaires in the clinic or infusion room on one of their regularly scheduled visit.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent. * Planning to receive chemotherapy at Massachusetts General Hospital * Ability to read and respond to questions in English.

Exclusion criteria

* Prior chemotherapy for current stage of disease.

Design outcomes

Primary

MeasureTime frame
Completion of surveys1 year

Secondary

MeasureTime frame
Patients perceptions of prognosis, goals of care, and communication with providers1 year
Quality of end of life care1 year
Survival1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026